BioSpace News Archive

Mereo BioPharma Group plc, a clinical stage biopharmaceutical company focused on oncology and rare diseases, announced positive data from an interim analysis of an investigator-initiated study of alvelestat in patients with Bronchiolitis Obliterans Syndrome following hematopoietic stem cell transplantation.

Rain Therapeutics Inc., a clinical-stage company developing precision oncology therapeutics, announced a patient referral partnership with Caris Life Sciences.

Immutep Limited, a biotechnology company developing novel immunotherapy treatments for cancer and autoimmune disease, is pleased to announce the grant of patent number EP3473263 entitled “Combined Preparations for the Treatment of Cancer” by the European Patent Office.

InspireMD, Inc. developer of the CGuard™ Embolic Prevention System for the prevention of stroke caused by Carotid Artery Disease, announced that Chief Executive Officer Marvin Slosman will present a corporate overview at the three-day LD Micro Virtual Invitational Conference being held on June 8 – 10, 2021.

Company launches Advanced Biopharma Solutions (ABS), as the first pillar of the program, to enable spatial biomarker-guided drug development and clinical trials

Travere Therapeutics, Inc. (NASDAQ: TVTX) today announced completion of patient enrollment in the Phase 3 PROTECT Study.

Soleno Therapeutics, Inc. (“Soleno”) (NASDAQ: SLNO), a clinical-stage biopharmaceutical company developing novel therapeutics for the treatment of rare diseases, today announced that the U.S. Food and Drug Administration (FDA) has granted its investigational drug, DCCR (diazoxide choline) Extended-Release tablets, Orphan Drug Designation for the treatment of Glycogen Storage Disease Type 1a (GSD 1a), or von Gierke disease

PharmAbcine Inc., a clinical-stage biotech company focusing on the development of antibody therapeutics, announced that the company will participate in BIO Digital International Convention.

Kintara Therapeutics, Inc., a biopharmaceutical company focused on the development of new solid tumor cancer therapies, announced that Chief Executive Officer Saiid Zarrabian will present a corporate overview at the three-day LD Micro Virtual Invitational Conference being held on June 8 – 10, 2021.

Wolters Kluwer, Health announced that the Ministry of Health of Mongolia is now providing healthcare professionals throughout the country of three million people with full access to UpToDate, the clinical decision support resource trusted by more than two million clinicians worldwide.